|
|
|
|
|
76.
141 Accesses
|
Microarray analysis of Foxl2 mediated gene regulation in the mouse ovary derived KK1 granulosa cell line: Over-expression of Foxl2 leads to activation of the gonadotropin releasing hormone receptor gene promoter
Jean M Escudero, Jodi L Haller, Colin M Clay, Kenneth W Escudero Journal of Ovarian Research 2010, 3:4 (18 February 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
77.
139 Accesses
|
Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: weight-dependent relationships with endocrine and metabolic traits
Carmen E Pepene Journal of Ovarian Research 2013, 6:4 (22 January 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
78.
138 Accesses
|
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression
Deep Agnani, Olga Camacho-Vanegas, Catalina Camacho, Shashi Lele, Kunle Odunsi, Samantha Cohen, Peter Dottino, John A Martignetti Journal of Ovarian Research 2011, 4:18 (22 October 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
79.
138 Accesses
|
Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis
Megan S Rice, Megan A Murphy, Shelley S Tworoger Journal of Ovarian Research 2012, 5:13 (15 May 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
80.
136 Accesses
|
The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers
Kyung-Jin Min, Kyeong A So, Yung-Taek Ouh, Jin-Hwa Hong, Jae-Kwan Lee Journal of Ovarian Research 2012, 5:28 (15 October 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
81.
135 Accesses
|
MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells
Moorthy P Ponnusamy, Parthasarathy Seshacharyulu, ArokiaPriyanka Vaz, Parama Dey, Surinder K Batra Journal of Ovarian Research 2011, 4:7 (26 April 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
82.
135 Accesses
|
Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
Christine Madsen, Karina Steffensen, Dorte Olsen, Marianne Waldstrøm, Maja Smerdel, Parvin Adimi, Ivan Brandslund, Anders Jakobsen Journal of Ovarian Research 2012, 5:23 (19 September 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
83.
133 Accesses
|
Clinical outcome of fresh and vitrified-warmed blastocyst and cleavage-stage embryo transfers in ethnic Chinese ART patients
Guo Tong, Shan Cao, Xun Wu, Jun Zhang, Ji Cui, Boon Heng, Xiu Ling Journal of Ovarian Research 2012, 5:27 (5 October 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
84.
131 Accesses
|
Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype
Nicholas B Berry, Sharmila A Bapat Journal of Ovarian Research 2008, 1:8 (24 November 2008)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
85.
131 Accesses
|
Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
Fang Wang, Bolan Yu, Wenjing Yang, Jianqiao Liu, Jiachun Lu, Xuefeng Xia Journal of Ovarian Research 2012, 5:15 (18 May 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
86.
130 Accesses
|
Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary
Takashi Yamada, Takayoshi Kanda, Hiroshi Mori, Kaname Shimokawa, Mitsuo Kagawa, Yuro Shibayama Journal of Ovarian Research 2013, 6:8 (4 February 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
87.
128 Accesses
|
Health-related quality of life in women with endometriosis: a systematic review
Shuang-zheng Jia, Jin-hua Leng, Jing-hua Shi, Peng-ran Sun, Jing-he Lang Journal of Ovarian Research 2012, 5:29 (18 October 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
88.
126 Accesses
|
Effects of GnRH agonist treatment on steroidogenesis and folliculogenesis in the ovary of cyclic mice
Padmasana Singh, Amitabh Krishna Journal of Ovarian Research 2010, 3:26 (18 November 2010)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
89.
125 Accesses
|
Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis
Atsushi Hayashi, Akiko Tanabe, Sachiko Kawabe, Mika Hayashi, Hiroko Yuguchi, Yoshiki Yamashita, Kiyoji Okuda, Masahide Ohmichi Journal of Ovarian Research 2012, 5:31 (1 November 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
90.
124 Accesses
|
Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
Digant Gupta, Carolyn A Lammersfeld, Pankaj G Vashi, Donald P Braun Journal of Ovarian Research 2010, 3:22 (12 October 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
91.
124 Accesses
|
Analysis of ovarian tumor pathology by Fourier Transform Infrared Spectroscopy
Ranjana Mehrotra, Gunjan Tyagi, Deepak K Jangir, Ramesh Dawar, Noopur Gupta Journal of Ovarian Research 2010, 3:27 (21 December 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
92.
124 Accesses
|
Squamous cell carcinoma in situ arising in mature cystic teratoma of the ovary: a case report
Fatima A Zakkouri, Saloua Ouaouch, Saber Boutayeb, Mouna Rimani, Lamiae Gamra, Hind Mrabti, Hassan Errihani Journal of Ovarian Research 2011, 4:5 (24 March 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
93.
120 Accesses
|
Technical challenges and limitations of current mouse models of ovarian cancer
Kenneth Garson, Lisa F Gamwell, Elizabeth MG Pitre, Barbara C Vanderhyden Journal of Ovarian Research 2012, 5:39 (29 November 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
94.
118 Accesses
|
Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients
Michael F Gallagher, Richard J Flavin, Salah A Elbaruni, Jamie K McInerney, Paul C Smyth, Yvonne M Salley, Sebastian F Vencken, Sharon A O'Toole, Alexandros Laios, Mathia YC Lee, Karen Denning, Jinghuan Li, Sinead T Aherne, Kai Q Lao, Cara M Martin, Orla M Sheils, John J O'Leary Journal of Ovarian Research 2009, 2:19 (16 December 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
95.
118 Accesses
|
Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis
Angela Falbo, Francesco Orio, Roberta Venturella, Erika Rania, Caterina Materazzo, Achille Tolino, Fulvio Zullo, Stefano Palomba Journal of Ovarian Research 2009, 2:5 (31 May 2009)
Abstract | Full text | PDF
| PubMed
|
|
|
96.
117 Accesses
|
BMP-2 signaling in ovarian cancer and its association with poor prognosis
Cécile Le Page, Marie-Line Puiffe, Liliane Meunier, Magdalena Zietarska, Manon de Ladurantaye, Patricia N Tonin, Diane Provencher, Anne-Marie Mes-Masson Journal of Ovarian Research 2009, 2:4 (14 April 2009)
Abstract | Full text | PDF
| PubMed
|
|
|
97.
116 Accesses
|
Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats
Anjali Priyadarshani, Krishna Chuttani, Gaurav Mittal, Aseem Bhatnagar Journal of Ovarian Research 2010, 3:10 (27 April 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
98.
116 Accesses
|
Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome
Nese Cinar, Ayla Harmanci, Duygu Aksoy, Kadriye Aydin, Bulent Yildiz Journal of Ovarian Research 2012, 5:42 (7 December 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
99.
115 Accesses
|
Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells
James J Rough, M Alexandra Monroy, Smitha Yerrum, John M Daly Journal of Ovarian Research 2010, 3:13 (26 May 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
100.
115 Accesses
|
CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion
Erica L Johnson, Rajesh Singh, Crystal M Johnson-Holiday, William E Grizzle, Edward E Partridge, James W Lillard, Shailesh Singh Journal of Ovarian Research 2010, 3:15 (17 June 2010)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
CCR9-CCL25 signalling promotes the survival of ovarian cancer cells and resistance to the chemotherepeutic cisplatin predominately through the PI3K/Akt pathwayand PI3K inhibition negates CCL25-mediated and CCR9-dependent cisplatin resistance.
|